Role of Sclerostin in Mastocytosis Bone Disease
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY
Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues. Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Age \> 18 years
• Mastocytosis defined according to WHO criteria
• Known KIT mutation status
Locations
Other Locations
Poland
Department of Hematooncology and Bone Marrow Transplantation
RECRUITING
Lublin
Contact Information
Primary
Aneta Szudy-Szczyrek, MD., PhD.
aneta.szudy-szczyrek@umlub.pl
+48815345468
Time Frame
Start Date: 2019-09-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Leads: Medical University of Lublin